Morse Asset Management’s Teladoc Health TDOC Stock Holding History

Morse Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,500	Closed	-$329K	–	155
2020 Q3	$329K	Buy	+1,500	New	+$318K	0.11%	108
2020 Q2	–	Sell	-4,700	Closed	-$729K	–	123
2020 Q1	$729K	Buy	4,700 +1,100	+31%	+$128K	0.35%	63
2019 Q4	$301K	Buy	+3,600	New	+$274K	0.1%	111

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morse Asset Management's TDOC Position: Q4 2020 in Review

Morse Asset Management sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 1,500 shares — an estimated $329K sold.

Morse Asset Management first reported a position in TDOC in Q4 2019 and held it in 3 quarters. The position peaked at $729K in Q1 2020. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Morse Asset Management reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
Morse Asset Management sold 1,500 Teladoc Health shares in Q4 2020, an estimated $329K.
Morse Asset Management first reported a position in Teladoc Health in Q4 2019 and held it in 3 quarters.
Morse Asset Management's Teladoc Health position peaked at $729K in Q1 2020.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Morse Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.